Levetiracetam-Induced Pancytopenia

被引：20

作者：

Elouni, Bouraoui ^{[1
]}

Salem, Chaker Ben ^{[2
]}

Biour, Michel ^{[3
]}

机构：

[1] Hop St Antoine, Ctr Pharmacovigilance, F-75571 Paris 12, France

[2] Fac Med Sousse, Dept Clin Pharmacol, Sousse, Tunisia

[3] Hop St Antoine, Pharmacovigilance Reg Ctr, F-75571 Paris, France

来源：

ANNALS OF PHARMACOTHERAPY | 2009年 / 43卷 / 05期

关键词：

THROMBOCYTOPENIA; THERAPY;

D O I：

10.1345/aph.1L727

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：985 / 985

页数：1

共 6 条

[1] Evidence for sustained efficacy of levetiracetam as add-on epilepsy therapy [J].

Ben-Menachem, E ;

Edrich, P ;

Van Vleymen, B ;

Sander, JWA ;

Schmidt, B .

EPILEPSY RESEARCH, 2003, 53 (1-2) :57-64

[2] Worsening of an immune thrombocytopenia during monotherapy with levetiracetam [J].

Hartmann, H ;

Schumacher, U ;

Seeck, M .

AKTUELLE NEUROLOGIE, 2002, 29 (09) :467-468

[3] Levetiracetam-induced thrombocytopenia [J].

Kimland, E ;

Höjeberg, B ;

von Euler, M .

EPILEPSIA, 2004, 45 (07) :877-878

[4] Thrombocytopenia during levetiracetam therapy [J].

Meschede, A. ;

Runge, U. ;

Sabolek, M. .

EPILEPSY RESEARCH, 2008, 80 (01) :91-92

[5] A METHOD FOR ESTIMATING THE PROBABILITY OF ADVERSE DRUG-REACTIONS [J].

NARANJO, CA ;

BUSTO, U ;

SELLERS, EM ;

SANDOR, P ;

RUIZ, I ;

ROBERTS, EA ;

JANECEK, E ;

DOMECQ, C ;

GREENBLATT, DJ .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1981, 30 (02) :239-245

[6] The safety of levetiracetam [J].

Sirsi, Deepa ;

Safdieh, Joseph E. .

EXPERT OPINION ON DRUG SAFETY, 2007, 6 (03) :241-250

← 1 →